Molecule2Market Pty Ltd
Website: http://molecule2market.com.au/
Member Contact: Anne De Luca
Position: Director
Industry: R&D Services
Company Profile:
Established in 2012, Molecule2Market (M2M) is a boutique CRO dedicated to advancing Australia’s contribution to the research and development of innovative medical treatments. With every study managed by a team member with over 20 years’ experience the M2M team provides high quality services across all phases of clinical research and a broad range of therapeutic areas across Australia, and New Zealand and the USA.
M2M services cover all aspects of clinical research including:
· Project feasibility
· Site selection
· Study start-up (ethics/regulatory submissions, contract negotiation)
· Project Management
· Monitoring
· Safety reporting
· Quality review/ Audit
· Medical writing
· Local study sponsorship or Resident director role
M2M also offers the following services:
· Regulatory
· Data Management/ Statistics
· Medical Monitoring
· Support Australian R&D Tax Incentive
M2M is a proud member of the Association of International Contract Research Organizations (AICROS) - an alliance of local established CROs providing high quality clinical research services on a global scale.
